Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

RP2

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Replimune

Drug class:

CTLA4 inhibitor, G-CSF stimulant

Related drugs:

‹

pegfilgrastim (1)

pegfilgrastim-jmdb (0)

GW003 (balugrastim biosimilar) (0)

lenograstim (0)

Lonquex (lipegfilgrastim biosimilar) (0)

pegfilgrastim-apgf (0)

mecapegfilgrastim (0)

eflapegrastim-xnst (0)

G-CSF and polysialic acid (0)

pegfilgrastim-cbqv (0)

pegfilgrastim-bmez (0)

recombinant G-CSF (0)

ipilimumab (223)

tremelimumab (60)

cadonilimab (10)

iparomlimab/tuvonralimab (3)

ipilimumab biosimilar (CS1002) (2)

CTLA4 inhibitor (0)

IBI310 (ipilimumab biosimilar) (0)

prolgolimab/nurulimab (0)

PF-06753512 (0)

Nugraf (filgrastim biosimilar) (3)

pegfilgrastim (1)

pegfilgrastim-jmdb (0)

GW003 (balugrastim biosimilar) (0)

lenograstim (0)

Lonquex (lipegfilgrastim biosimilar) (0)

pegfilgrastim-apgf (0)

mecapegfilgrastim (0)

eflapegrastim-xnst (0)

G-CSF and polysialic acid (0)

pegfilgrastim-cbqv (0)

pegfilgrastim-bmez (0)

recombinant G-CSF (0)

›